Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Mol Oral Microbiol. 2011 Dec 23;27(2):57–69. doi: 10.1111/j.2041-1014.2011.00634.x

Table 1.

Characterized mutacins

Name Mature peptide Sequence Producer strains Regulator
Lantibiotics*
Mutacin I FSSLSLCSLGCTGVKNPSFNSYCC UA140, CH43 MutR
Mutacin II NRWWQGVVPTVSYECRMNSWQHVFTCC T8 MutR
Mutacin III/1140 FKSWSLCTPGCARTGSFNSYCC UA787, JH1140 MutR
Mutacin B-NY266 FKSWSFCTPGCAKTGSFNSYCC NY266
Mutacin Smb STPACAIGVVGITVAVTGISTACTSRCINK (SmbA)
GTTVVNSTFSIVLGNKGYICTVTVECMRNCSK (SmbB)		 GS5 ComE, HdrR?, BrsR?
Mutacin K8 MGKGAVGTISHECRYNSWAFLATCCS K8 MukR?
Non-lantibiotics
Mutacin IV KVSGGEAVAAIGICATASAAIGGLAGATLVTPYCVGTWGLIRSH (NlmA)
DKQAADTFLSACGGAASGFTYCASNGVWHPYILAGCAGVGAVGSVVFPH (NlmB)		 UA140, UA159, 25175, L13 ComE, HdrR, BrsR
Mutacin V GRGWNCAAGIALGAGQGYMATAGGTAF
LGPYAIGTGAFGAIAGGIGGALNSCG		 UA159, UA140 ComE, HdrR, BrsR
Mutacin VI GMIRCALGTAGSAGLGFVGGMGAGTVT
LPVVGTVSGAALGGWSGAAVGAATFC		 UA159 ComE, HdrR, BrsR
Mutacin N SRQAADTFLSGAYGAAKGVTARASTGVYVVPATLVALGVYGAGLNIAFP N ComE?
*

Bold letters denote residues involved in thioether linkages in the mature peptide.